Numans Health Food Holdings Company Limited (HK:2530)
:2530
Top Page
Numans Health Food Holdings Company Limited
(2530)
Select Model
Select Model
Rating:67Neutral
Price Target:
HK$0.62
▲(4.75% Upside)
Action:DowngradedDate:01/09/26
The score is driven primarily by solid financial stability and profitability metrics (notably low leverage and strong margins), tempered by meaningful revenue and margin deterioration and weakening free cash flow. Technically, the stock screens weak versus major moving averages, while valuation is helped by a high dividend yield and a moderate P/E.
Positive Factors
Very low leverage and strong equity base
A near-zero debt-to-equity ratio and a 91% equity ratio create a durable capital structure that reduces refinancing and interest-rate risks. This financial flexibility supports stable operations, capacity to fund organic growth or capex, and resilience across economic cycles over the next months.
Negative Factors
Sharp recent revenue contraction
A roughly one-third drop in revenue materially weakens the business' scale economics and market footprint. Persisting top-line decline can erode negotiating leverage, reduce fixed-cost absorption, and constrain investment, posing a sustained headwind to growth and margins.
Read all positive and negative factors
Positive Factors
Negative Factors
Very low leverage and strong equity base
A near-zero debt-to-equity ratio and a 91% equity ratio create a durable capital structure that reduces refinancing and interest-rate risks. This financial flexibility supports stable operations, capacity to fund organic growth or capex, and resilience across economic cycles over the next months.
Read all positive factors
Numans Health Food Holdings Company Limited (2530) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$590.00M
Dividend Yield8.95%
Average Volume (3M)43.20K
Price to Earnings (P/E)73.3
Beta (1Y)0.38
Revenue Growth-41.06%
EPS Growth-74.96%
CountryHK
Employees44
SectorConsumer Goods
Sector StrengthN/A
IndustryPackaged Foods
Share Statistics
EPS (TTM)N/A
Shares Outstanding1,000,000,000
10 Day Avg. Volume61,600
30 Day Avg. Volume43,200
Financial Highlights & Ratios
PEG Ratio-0.16
Price to Book (P/B)1.72
Price to Sales (P/S)2.34
P/FCF Ratio7.87
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Numans Health Food Holdings Company Limited Business Overview & Revenue Model
Company Description
Numans Health Food Holdings Company Limited engages in the marketing, sales, and distribution of finished nutritional products under the Nemans brand name in the People's Republic of China. It offers algal oil docosahexaenoic acid for development ...
How the Company Makes Money
Numans Health Food Holdings generates revenue primarily through the sale of its health food products across various channels, including retail, online marketplaces, and direct-to-consumer sales. Key revenue streams include the sale of dietary supp...
Numans Health Food Holdings Company Limited Financial Statement Overview
Summary
Income Statement
75
Positive
Balance Sheet
80
Positive
Cash Flow
70
Positive
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 242.62M | 277.50M | 426.55M | 367.30M | 337.61M |
| Gross Profit | 177.14M | 211.06M | 320.87M | 273.19M | 246.60M |
| EBITDA | 70.28M | 103.76M | 199.86M | 103.60M | 157.81M |
| Net Income | 34.42M | 74.90M | 159.34M | 87.52M | 119.67M |
Balance Sheet | |||||
| Total Assets | 631.04M | 415.59M | 470.02M | 403.58M | 288.81M |
| Cash, Cash Equivalents and Short-Term Investments | 463.74M | 235.82M | 262.56M | 192.84M | 152.66M |
| Total Debt | 8.84M | 4.43M | 5.83M | 7.45M | 1.23M |
| Total Liabilities | 88.19M | 39.07M | 59.94M | 156.34M | 86.29M |
| Stockholders Equity | 542.85M | 376.52M | 410.08M | 247.24M | 202.52M |
Cash Flow | |||||
| Free Cash Flow | 74.69M | 82.33M | 149.95M | 39.42M | 93.00M |
| Operating Cash Flow | 74.74M | 83.46M | 150.57M | 44.31M | 93.99M |
| Investing Cash Flow | -53.22K | 2.04M | 1.57M | -4.14M | -519.00K |
| Financing Cash Flow | 62.91M | -113.48M | -83.79M | -8.55M | -29.31M |
Numans Health Food Holdings Company Limited Technical Analysis
Negative
0.59
Price Trends
0.60
Negative
0.63
Negative
Market Momentum
>-0.01
Negative
51.32
Neutral
100.00
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2530, the sentiment is Negative. The current price of 0.59 is below the 20-day moving average (MA) of 0.59, below the 50-day MA of 0.60, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 51.32 is Neutral, neither overbought nor oversold. The STOCH value of 100.00 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:2530.
Numans Health Food Holdings Company Limited Peers Comparison
UnderperformOutperform
Sector (57)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | HK$3.87B | 7.35 | 9.86% | 3.74% | 11.89% | 27.80% | |
73 Outperform | HK$350.00M | 16.96 | 4.00% | 0.78% | 5.43% | -25.42% | |
72 Outperform | HK$1.05B | 5.35 | 4.37% | 5.38% | -6.58% | 16.23% | |
70 Outperform | HK$212.54M | 13.18 | 4.03% | 47.72% | 7.35% | ― | |
70 Outperform | HK$1.22B | 7.67 | 5.61% | 10.44% | -1.19% | -9.05% | |
67 Neutral | HK$590.00M | 73.32 | 7.49% | 8.95% | -41.06% | -74.96% | |
57 Neutral | $3.13B | 9.23 | -34.32% | 3.14% | -25.56% | -353.61% |
* Consumer Goods Sector Average
HK:2530
Numans Health Food Holdings Company Limited
0.59
-0.02
-3.28%
HK:0926
Besunyen Holdings Co. Ltd.
2.43
0.48
24.42%
HK:1767
TS Wonders Holding Limited
0.35
0.16
84.21%
HK:1837
Natural Food International Holding Ltd.
1.77
1.22
221.82%
HK:2317
Vedan International (Holdings) Ltd.
0.80
0.24
42.86%
HK:3838
China Starch Holdings Limited
0.18
<0.01
4.14%
Numans Health Food Holdings Company Limited Corporate Events
Numans Health Food Deploys Idle Cash Into RMB34 Million Lenovo Share Purchase
Jan 12, 2026
Numans Health Food Holdings Company Limited has used surplus internal cash resources to acquire 4 million shares in Lenovo Group on the open market for about RMB34.1 million, at an average price of roughly RMB8.524 per share, in a transaction clas...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.